News

Revance Reports Positive Results from ASPEN-1 Phase 3 Trial of DaxibotulinumtoxinA for Injection in Cervical Dystonia

Apr 27, 2021

InStyle

Experts Call These the Most Cutting-Edge Aesthetic Treatments Learn More

Apr 27, 2021

Seeking Alpha

Enrollment underway in Revance Therapeutics’ late-stage DaxibotulinumtoxinA study Learn More

Apr 20, 2021

MedEsthetics

Bringing Botulinum Toxin Trials Closer to Real-Life Conditions Learn More

Apr 16, 2021

SHAPE

The Shape 2021 Skin Awards Will Give You the Glow-Up This Year Needs Learn More

Jan 29, 2021

Modern Aesthetics

Revance: ePosters Showcase Data for DaxibotulinumtoxinA and RHA Line at Maui Derm Learn More

Dec 22, 2020

Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection Learn More

Dec 21, 2020

Practical Dermatology

For Upper Facial Lines, DaxibotulinumtoxinA Succeeds in Phase 2 Learn More

Dec 16, 2020

Business Wire

Governor Lee, Commissioner Rolfe Announce Revance Therapeutics to Relocate Global Headquarters to Nashville Learn More

Oct 20, 2020

Neurology Live

DaxibotulinumtoxinA Meets Primary End Point in Cervical Dystonia Study Learn More

Aug 26, 2020

Modern Aesthetics

Revance Commercial Infrastructure to Roll Out RHA Collection of Dermal Fillers Learn More

Aug 25, 2020

Revance Commercial Infrastructure Established and Positioned to Launch Prestige Aesthetics Portfolio with the RHA® Collection of Dermal Fillers Learn More

Job Opportunities

Do you have what it takes to join our team? Check out our Careers page and find out.

Search Jobs

Latest News:

Job Opportunities

Aesthetics

Therapeutics

Investors

Company

Careers